Review articlePublished 29 Jun 2018
Targeting Prion-like Cis Phosphorylated Tau Pathology in Neurodegenerative Diseases
1Division of Translational Therapeutics, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, CLS, Boston, MA, USA; 2Cancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, CLS, Boston, MA, USA; 3Broad Institute of Harvard University and Massachusetts Institute of Technology, Cambridge, MA, USA; 4Fujian Key Laboratory for Translational Research in Cancer and Neurodegenerative Diseases, Institute for Translational Medicine Fujian Medical University, Fuzhou, Fujian, China
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Alzheimers Disease & Parkinsonism
- SubjectNeuroscience & Neurology
- BylineArticles whose byline prints “Onder Albayram”
- BylineArticles whose byline prints “Peter Angeli”
- BylineArticles whose byline prints “Elizabeth Bernstein”
- BylineArticles whose byline prints “Sean Baxley”
- BylineArticles whose byline prints “Ziang Gao”
- BylineArticles whose byline prints “Kun Ping Lu”
- BylineArticles whose byline prints “Xiao Zhen Zhou”